Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cronos Group Inc (CRON) vs Gemini Space Station Inc (GEMI) Price & Performance

Cronos Group IncTrade
Gemini Space Station IncTrade

Price performance (Past 24H)

Key statistics

Cronos Group Inc vs Gemini Space Station Inc — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.18B), while Gemini Space Station Inc trades at $4.43 (market cap $579.55M). The key difference: Cronos Group Inc is far larger — about 2× Gemini Space Station Inc's market cap, and Cronos Group Inc is trading nearer its 52-week high, Gemini Space Station Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Gemini Space Station Inc for 14 Days on average.

CRONGEMI
Market Cap
$1.18B$579.55M
Volume
968,0371,882,406
Sector
HealthFinancials
52-Week High
$3.55$25.41
52-Week Low
$2.30$3.54
Typical Hold Time
22 Days14 Days
Enterprise Value
$387.62M$558.57M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cronos Group Inc

CRON trades at $3.24, down 1.37% today amid a bearish technical signal. Recent quarterly earnings show beats in Q1 and Q2 2026, with revenue growth from $118M in 2024 to $147M in 2025. The company reported a net loss of $9.45M in 2025 but projects a profit of $70M for 2026. Analyst sentiment is mixed with a 20% buy rating. News highlights focus on international expansion and a recent Investor Day outlining growth strategies.

Outlook is cautiously optimistic given projected profitability in 2026 and strong cash reserves, but risks include sustained negative cash flow and competitive pressures. The stock's valuation metrics like P/E of 16.95 and P/S of 6.84 suggest moderate pricing relative to peers, though high EV/EBITDA of 43 indicates premium expectations.

Gemini Space Station Inc

Gemini Space Station (GEMI) trades at $4.43, down 1.34% on the day, with a bearish technical outlook despite recent price surges. The company reported Q2 2026 revenue growth of 37% year-over-year but continues to post significant losses, with a net income margin of -250.13%. Recent news highlights expansion into commission-free stock trading and prediction markets, though the stock faces headwinds from earnings misses and ongoing class action lawsuits.

The investment outlook remains high-risk due to persistent unprofitability and negative cash flow from operations. While analyst consensus suggests modest upside to a $5.25 price target, the stock's viability depends on achieving profitability amid competitive pressures and regulatory scrutiny. Current valuation metrics appear stretched given the company's fundamental challenges.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CRON

No sentiment data available yet.

GEMI
30% Buy70% Sell
Avg holding period · 14 Days

Top news

Latest headlines on both assets

About Cronos Group Inc

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.

Read more on CRON →

About Gemini Space Station Inc

Gemini Space Station Inc is the parent company of the Gemini crypto ecosystem, founded by Cameron and Tyler Winklevoss. It operates as a regulated digital asset exchange and custodian, providing a platform for individuals and institutions to trade, store, and stake cryptocurrencies while serving as a trusted bridge between legacy finance and the decentralized web.

Read more on GEMI →